Skip to content
Forge Biologics
  • About
    • About
    • Mission & Approach
    • Leadership
    • Board
  • Manufacturing Solutions
    • Manufacturing Solutions
    • Plasmid DNA
    • AAV
    • Technology
  • Science
    • Science
    • Pipeline
    • About Gene Therapy
    • FBX-101 for Krabbe Disease
  • Careers
  • News & Insights
    • News
    • Events
    • Insights
    • Media Kit
  • Connect

clinical trials

Forge Biologics Cleared for Clinical Trial of FBX-101, a Krabbe Disease Treatment
FDA Clearance of Investigational New Drug for Patients with Krabbe Disease
United Leukodystrophy Foundation
RESKUE Trial for Patients with Krabbe Disease
FDA Clearance of Investigational New Drug for Patients with Krabbe Disease
Copyright Forge Biologics - All Rights Reserved Terms & Conditions | Privacy Policy